CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 167 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$7,688,000
+61.0%
82,718
+3.2%
0.01%
+50.0%
Q3 2021$4,774,000
-17.0%
80,171
-4.9%
0.01%
-14.3%
Q2 2021$5,750,000
-5.5%
84,317
-3.8%
0.01%
-12.5%
Q1 2021$6,084,000
-10.1%
87,677
-0.4%
0.01%
-11.1%
Q4 2020$6,765,000
+2.8%
88,049
+0.0%
0.01%
-18.2%
Q3 2020$6,582,000
+23.1%
88,006
+3.6%
0.01%
+22.2%
Q2 2020$5,345,000
+65.8%
84,912
+10.6%
0.01%
+28.6%
Q1 2020$3,224,000
-8.0%
76,758
-0.5%
0.01%
+16.7%
Q4 2019$3,504,000
-1.7%
77,138
-0.9%
0.01%
-14.3%
Q3 2019$3,563,000
-21.0%
77,854
+1.2%
0.01%
-22.2%
Q2 2019$4,510,000
+32.4%
76,924
+1.2%
0.01%
+28.6%
Q1 2019$3,407,000
+12.6%
76,008
-2.2%
0.01%0.0%
Q4 2018$3,026,000
-13.2%
77,698
+2.5%
0.01%0.0%
Q3 2018$3,487,000
+5.3%
75,776
-0.3%
0.01%0.0%
Q2 2018$3,312,000
+14.9%
75,973
+4.1%
0.01%
+16.7%
Q1 2018$2,883,000
+36.9%
72,984
+17.7%
0.01%
+50.0%
Q4 2017$2,106,000
+31.2%
61,983
-1.5%
0.00%0.0%
Q3 2017$1,605,000
+67.5%
62,932
+10.8%
0.00%
+100.0%
Q2 2017$958,00056,7960.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Prosight Management, LP 139,528$6,083,0004.46%
Eversept Partners, LP 134,151$5,848,9842.68%
DAFNA Capital Management LLC 95,242$4,153,0001.94%
GREAT POINT PARTNERS LLC 302,000$13,167,0001.82%
Atika Capital Management LLC 190,000$8,284,0001.59%
Crawford Lake Capital Management, LLC 205,688$8,968,0001.57%
Crawford Lake Capital Management, LLC 205,600$8,964,0001.57%
Cormorant Asset Management, LP 450,000$19,620,0001.45%
SENZAR ASSET MANAGEMENT, LLC 11,123$485,0001.40%
Rhenman & Partners Asset Management AB 284,621$12,409,0001.27%
View complete list of ARENA PHARMACEUTICALS INC shareholders